시장보고서
상품코드
1593484

혈액 배양 검사 시장 규모, 점유율 및 성장 분석(기술별, 용도별, 최종 용도별, 지역별) : 산업 예측(2024-2031년)

Blood Culture Tests Market Size, Share, Growth Analysis, By Technique (Conventional, Automated), By Application (Bacterial Infections, Fungal Infections), By End Use (Hospital Laboratories, Reference Laboratories), By Region -Industry Forecast 2024-2031

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 198 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 혈액 배양 검사 시장 규모는 2022년 61억 6,000만 달러로 평가되었고, 2023년 69억 2,000만 달러에서 2031년 175억 달러에 이르고, 예측 기간(2024-2031년) 동안 12.3%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계 혈액 배양 검사 시장은 혈류감염증(BSI)에 대한 혁신적인 진단제품의 승인 증가와 BSI 유병률 증가에 힘입어 큰 폭의 성장세를 보이고 있습니다. 혈액 배양 검사는 혈류 내 박테리아 및 곰팡이와 같은 유해한 미생물을 식별하는 데 매우 중요합니다. 이 진단 절차는 혈액 샘플을 추출하고 무균 환경에서 배양하여 이러한 병원균의 증식을 촉진하여 패혈증과 같은 심각한 상태로 이어질 수 있는 감염을 식별할 수 있습니다. 적시에 정확한 검사 결과는 의료 전문가가 항균제 치료를 처방하고, 환자 치료를 개선하고, 감염 확산을 억제하고, 회복 결과를 향상시키는 데 필수적인 지침이 됩니다. 이러한 검사는 효과적인 감염 관리에 있어 매우 중요한 역할을 하기 때문에 수요가 증가하고 있습니다.

목차

서론

  • 분석 목적
  • 분석 범위
  • 정의

분석 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터 방법
  • 시장 규모 예측
  • 시장 상정과 제한

주요 요약

  • 세계 시장 전망
  • 수급 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 성장 억제요인과 과제
  • Porter's Five Forces 분석과 영향
    • 경쟁 기업간 경쟁 관계
    • 대체품의 위협
    • 바이어의 교섭력
    • 신규 진출업체의 위협
    • 공급 기업의 교섭력

주요 시장 인사이트

  • 중요 성공 요인
  • 경쟁 정도
  • 주요 투자 기회
  • 시장 생태계
  • 기술 진보
  • 규제 상황
  • 특허 분석
  • 밸류체인 분석
  • 가격 분석

세계의 혈액 배양 검사 시장 규모(방법별)·CAGR(2024-2031년)

  • 시장 개요
  • 기존 방법/수동식
  • 자동식 방법

세계의 혈액 배양 검사 시장 규모(제품별)·CAGR(2024-2031년)

  • 시장 개요
  • 소모품
  • 혈액 배양 배지
  • 호기성 혈액 배양 배지
  • 소아 호기성 혈액 배양 배지
  • 혐기성 혈액 배양 배지
  • 결핵균 혈액 배양 배지
  • 진균/효모 혈액 배양 배지
  • 어세이 키트 및 시약
  • 혈액 배양 액세서리
  • 기기
  • 자동 혈액 배양 시스템
  • 실험장치 지원
  • 인큐베이터
  • 콜로니 카운터
  • 현미경
  • 그램 염색 장비
  • 소프트웨어 및 서비스

세계의 혈액 배양 검사 시장 규모(기술별)와 CAGR(2024-2031년)

  • 시장 개요
  • 배양 기반 테크놀러지
  • 분자 기술
  • 마이크로어레이
  • PCR(중합효소 연쇄반응)
  • PNA-FiSH
  • 단백질체학 기술

세계의 혈액 배양 검사 시장 규모(용도별)·CAGR(2024-2031년)

  • 시장 개요
  • 균혈증
  • 진균혈증
  • 결핵균 감지

세계의 혈액 배양 검사 시장 규모(최종사용자별)·CAGR(2024-2031년)

  • 시장 개요
  • 병원 검사실
  • 참고 검사실
  • 학술용 연구실
  • 기타 검사실

세계의 혈액 배양 검사 시장 규모·CAGR(2024-2031년)

  • 북미(방법별, 제품별, 기술별, 용도별, 최종사용자별)
    • 미국
    • 캐나다
  • 유럽(방법별, 제품별, 기술별, 용도별, 최종사용자별)
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타 유럽
  • 아시아태평양(방법별, 제품별, 기술별, 용도별, 최종사용자별)
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카(방법별, 제품별, 기술별, 용도별, 최종사용자별)
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카(방법별, 제품별, 기술별, 용도별, 최종사용자별)
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 정보

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채택한 전략
  • 시장 최근 동향
  • 기업의 시장 점유율 분석(2023년)
  • 주요 기업 개요
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 매출 전년대비 비교(2021년-2023년)

주요 기업 개요

  • Abbott(미국)
  • F. Hoffmann-La Roche Ltd(스위스)
  • Novartis AG(스위스)
  • Eli Lilly and Company(미국)
  • Merck & Co., Inc.(미국)
  • Thermo Fisher Scientific Inc.(미국)
  • Siemens(독일)
  • Danaher Corporation(미국)
  • ZEPTOMETRIX(미국)
  • CytoTest Inc.(미국)
  • Devyser(스웨덴)
  • Bruker(미국)
  • BIOMERIEUX(프랑스)
  • Bayer AG(독일)
  • BD(미국)

결론과 추천 사항

LSH 24.11.28

Global Blood Culture Tests Market size was valued at USD 6.16 billion in 2022 and is poised to grow from USD 6.92 billion in 2023 to USD 17.50 billion by 2031, growing at a CAGR of 12.3% during the forecast period (2024-2031).

The global blood culture tests market is experiencing significant growth driven by the increasing approval of innovative diagnostic products for bloodstream infections (BSIs) and the rising prevalence of BSIs. Blood culture tests are critical in identifying harmful microorganisms such as bacteria or fungi in the bloodstream. This diagnostic procedure involves extracting a blood sample and cultivating it in a sterile environment to promote the growth of these pathogens, enabling the identification of infections that may lead to severe conditions like sepsis. Timely and accurate results are essential for guiding medical professionals in prescribing targeted antimicrobial treatments, improving patient care, reducing the spread of infections, and enhancing recovery outcomes. The demand for such tests is rising due to their crucial role in effective infection management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Culture Tests market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Culture Tests Market Segmental Analysis

Global Blood Culture Tests Market is segmented based on the Method, Product, Technology, Application, End-Use, and Region. Based on Product, the market is segmented into Conventional/Manual Methods, Automated Methods. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Technology, the market is segmented into Culture-based Technology, Molecular Technology, Proteomics Technology. Based on Application, the market is segmented into Bacteremia, Fungemia, Mycobacterial Detection. Based on End Use, the market is segmented into Hospital Laboratories, Reference Laboratories, Academic Research Laboratories, Other Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Blood Culture Tests Market

The rising global prevalence of bloodstream infections has significantly driven the demand for accurate and swift diagnostic solutions like blood culture tests. A 2023 World Health Organization report highlighted a notable rise in sepsis cases worldwide, underscoring the critical role of timely diagnosis in implementing effective treatment strategies. This growing urgency has led to increased investments in cutting-edge blood culture technologies, fueling advancements in the diagnostic solutions market aimed at combating infectious diseases. As a result, the blood culture tests market is experiencing accelerated growth, driven by the need for enhanced diagnostic accuracy and speed in addressing these life-threatening infections.

Restraints in the Global Blood Culture Tests Market

A significant restraint in the global blood culture tests market is the difficulty in interpreting blood culture results. Distinguishing between contaminants and clinically relevant pathogens requires specialized expertise, which can limit market growth by increasing reliance on skilled professionals and raising concerns about the accuracy of results. While improving training for medical personnel and enhancing reporting systems can help address these challenges, they do not fully resolve the complexities involved in interpreting the outcomes. This ongoing issue could hinder the widespread adoption and effectiveness of blood culture tests, as healthcare providers remain cautious about their reliability in diagnosing infections.

Market Trends of the Global Blood Culture Tests Market

One key trend in the global blood culture tests market is the growing emphasis on medical education and training programs. These initiatives are playing a pivotal role in raising awareness among healthcare professionals about the significant benefits of blood culture tests, particularly in the early and accurate diagnosis of sepsis. Workshops and seminars dedicated to sepsis management are becoming increasingly common, helping to underline the importance of timely blood culture testing. As awareness increases, it leads to improved patient care and creates crucial growth opportunities for the market. This heightened focus on education is driving the adoption of blood culture tests, further expanding their role in clinical settings.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • Pricing Analysis

Global Blood Culture Tests Market Size by Method & CAGR (2024-2031)

  • Market Overview
  • Conventional/Manual Methods
  • Automated Methods

Global Blood Culture Tests Market Size by Product & CAGR (2024-2031)

  • Market Overview
  • Consumables
  • Blood Culture Media
  • Aerobic Blood Culture Media
  • Pediatric Aerobic Blood Culture Media
  • Anaerobic Blood Culture Media
  • Mycobacterial Blood Culture Media
  • Fungi/Yeast Blood Culture Media
  • Assay Kits & Reagents
  • Blood Culture Accessories
  • Instruments
  • Automated Blood Culture Systems
  • Supporting Laboratory Equipment
  • Incubators
  • Colony Counters
  • Microscopes
  • Gram Stainers
  • Software and Service

Global Blood Culture Tests Market Size by Technology & CAGR (2024-2031)

  • Market Overview
  • Culture-Based Technology
  • Molecular Technologies
  • Microarrays
  • PCR (Polymerase Chain Reaction)
  • PNA-FiSH (Peptide Nucleic Acid - Fluroscent in Situ Hybridization)
  • Proteomics Technology

Global Blood Culture Tests Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Bacteremia
  • Fungemia
  • Mycobacterial Detection

Global Blood Culture Tests Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospital Laboratories
  • Reference Laboratories
  • Academic Research Laboratories
  • Other Laboratories

Global Blood Culture Tests Market Size & CAGR (2024-2031)

  • North America, (Method, Product, Technology, Application, End User)
    • US
    • Canada
  • Europe, (Method, Product, Technology, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Method, Product, Technology, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Method, Product, Technology, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Method, Product, Technology, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eli Lilly and Company (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZEPTOMETRIX (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CytoTest Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Devyser (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOMERIEUX (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제